SLC18A3 and pulmonary emphysema: These results suggest that VAChT levels, and consequently ACh release, can modulate lung inflammation in an emphysema model reinforcing previous data that ACh has an important protective role against pulmonary inflammation in different models of pulmonary diseases37,38.